Emerging approaches in MDS treatment
Ellen Ritchie, M.D., took part in an OncLive video series about Myelodysplastic Syndromes: Translating Genetics to Clinics.
"As a leukemia doctor, as well as an MDS physician, I’ve been really excited by seeing the results of immunotherapy, particularly in CLL (chronic lymphocytic leukemia) and ALL (acute lymphoblastic leukemia). And I’m excited about the next antibodies that may be targeting targets in myeloid diseases," she states in the most recent video, Emerging approaches in MDS treatment.
Other videos in the series include:
Hypomethylating Agents in MDS: Factors to Consider
Management of Patients with MDS and Cytopenias
Options in Low-Risk Myelodysplastic Syndrome
Treatment Goals for Lower Risk MDS
Parameters for Blood Transfusion in MDS
Comorbidities, Mutations, and Risk in MDS
Diagnostic Challenges: When Is It MDS
The Broad Spectrum of Myelodysplastic Syndrome